The Portea IPO looks like a rescue act
The draft prospectus of the nine-year-old health tech company is about a stagnant business and a brutal sector.
15 July, 2022•8 min
0
15 July, 2022•8 min
0
Getting your Trinity Audio player ready...
Why read this story?
Editor's note: Two weeks ago, home healthcare company Portea filed its draft initial public offering papers. The company, founded and run by serial entrepreneur couple K. Ganesh and Meena Ganesh in 2013, is the second health technology startup to attempt a public listing in the past year; the other one is online pharmacy PharmEasy, which filed a draft red herring prospectus late last year but hasn’t gone ahead with an IPO yet. From the series of startups backed by the Ganesh couple—including BigBasket, BlueStone and HomeLane—Portea is in fact the first to have filed for an IPO. And it is a fascinating one, to say the least. Portea, incorporated as Healthvista Ltd, is an out-of-hospital healthcare company. Its primary proposition is home care: primary, geriatric, palliative, post-operative, intensive and even mother and baby care. That’s about 60% of its revenue from operations. A good 20% comes from procuring pharmaceuticals from companies and selling them to its patients at a margin. The rest is from the sale and rental of medical equipment. In its draft red herring prospectus, Portea says it is the …
More in Internet
Internet
RBI’s fraud fix could give banks a headache
The regulator’s proposals to introduce checks and safety features in instant payments, if implemented, may end up testing banks.
You may also like
Business
IPO pipeline likely to stall despite SEBI flexibility
Promoters balk at smaller issues and uncertain pricing, choosing to wait out volatility.
Business
Epigamia’s Greek yogurt bet is finally paying off
A little over a decade after it was founded, the company that introduced India to Greek yogurt has pulled off a turnaround. But competition is rising fast and Epigamia can’t afford to simply rest on its laurels.
Business
MFs hold up India’s IPO market, their investors foot the bill
As retail interest in public issuances fades, mutual funds are filling the gap—funding promoter exits and delivering subpar returns to the very investors they represent.
